{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:25:56Z","timestamp":1761294356949,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T00:00:00Z","timestamp":1629763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Salivary gland cancer (SGC) is rare and a\u00a0heterogeneous type of cancer. Prospective randomized trials are lacking. No guideline focusing on standard procedures of radiotherapy (RT) in the treatment of SGC exists. Therefore, we surveyed the members of the German Society of Radiation Oncology (DEGRO) to gain information about current therapeutic strategies of SGC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An anonymous questionnaire was designed and made available on the online platform <jats:italic>umfrageonline.com<\/jats:italic>. The corresponding link was sent to all DEGRO members who provided their user data for contact purposes. Alternatively, a\u00a0PDF printout version was sent. Frequency distributions of responses for each question were calculated. The data were also analyzed by type of institution.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty-seven responses were received, including answers from 21\u00a0university departments, 22\u00a0non-university institutions, and 24\u00a0radiation oncology practices. Six participants reported that their departments (practice: <jats:italic>n<\/jats:italic>\u202f=\u20095, non-university hospital: <jats:italic>n<\/jats:italic>\u202f=\u20091) did not treat SGC, and therefore the questionnaire was not completed. Concerning radiation techniques, target volume definition, and concomitant chemotherapy, treatment strategies varied greatly among the participants. Comparing university vs. non-university institutions, university hospitals treat significantly more patients with SGC per year and initiated more molecular pathological diagnostics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SGC represents a\u00a0major challenge for clinicians, as reflected by the inhomogeneous survey results regarding diagnostics, RT approaches, and systemic therapy. Future prospective, multicenter clinical trials are warranted to improve and homogenize treatment of SGC and to individualize treatment according to histologic subtypes and risk factors.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00066-021-01833-x","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T15:03:02Z","timestamp":1629817382000},"page":"123-134","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Patterns of care analysis for salivary gland cancer: a\u00a0survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice"],"prefix":"10.1007","volume":"198","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9371-7814","authenticated-orcid":false,"given":"Jens","family":"von der Gr\u00fcn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus","family":"R\u00f6del","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Semrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlen","family":"Haderlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,24]]},"reference":[{"issue":"3","key":"1833_CR1","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/0360-3016(95)00122-F","volume":"32","author":"AS Garden","year":"1995","unstructured":"Garden\u00a0AS, Weber\u00a0RS, Morrison\u00a0WH, Ang\u00a0KK, Peters\u00a0LJ (1995) The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation. Int J Radiat Oncol Biol Phys 32(3):619\u2013626. https:\/\/doi.org\/10.1016\/0360-3016(95)00122-F","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1833_CR2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ijrobp.2004.03.018","volume":"61","author":"CH Terhaard","year":"2005","unstructured":"Terhaard\u00a0CH, Lubsen\u00a0H, Rasch\u00a0CR, Levendag\u00a0PC, Kaanders\u00a0HH, Tjho-Heslinga\u00a0RE et al (2005) The role of radiotherapy in the treatment of malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 61(1):103\u2013111. https:\/\/doi.org\/10.1016\/j.ijrobp.2004.03.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1833_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.radonc.2015.05.010","volume":"118","author":"AD Jensen","year":"2016","unstructured":"Jensen\u00a0AD, Poulakis\u00a0M, Nikoghosyan\u00a0AV, Welzel\u00a0T, Uhl\u00a0M, Federspil\u00a0PA et al (2016) High-LET radiotherapy for adenoid cystic carcinoma of the head and neck: 15\u00a0years\u2019 experience with raster-scanned carbon ion therapy. Radiother Oncol 118(2):272\u2013280. https:\/\/doi.org\/10.1016\/j.radonc.2015.05.010","journal-title":"Radiother Oncol"},{"key":"1833_CR4","unstructured":"National Comprehensive Cancer Network (2020) Head and neck cancers (Version 2.2020, June 09, 2020). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 20 Oct 2020"},{"issue":"2","key":"1833_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.oooo.2014.10.020","volume":"119","author":"Y Liu","year":"2015","unstructured":"Liu\u00a0Y, Li\u00a0J, Tan\u00a0YR, Xiong\u00a0P, Zhong\u00a0LP (2015) Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a\u00a0meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 119(2):238\u2013245.e2. https:\/\/doi.org\/10.1016\/j.oooo.2014.10.020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"4","key":"1833_CR6","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.oooo.2019.06.014","volume":"128","author":"X Kong","year":"2019","unstructured":"Kong\u00a0X, Li\u00a0H, Han\u00a0Z (2019) The diagnostic role of ultrasonography, computed tomography, magnetic resonance imaging, positron emission tomography\/computed tomography, and real-time elastography in the differentiation of benign and malignant salivary gland tumors: a\u00a0meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 128(4):431\u2013443.e1. https:\/\/doi.org\/10.1016\/j.oooo.2019.06.014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1833_CR7","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.oraloncology.2016.04.016","volume":"60","author":"N Freling","year":"2016","unstructured":"Freling\u00a0N, Crippa\u00a0F, Maroldi\u00a0R (2016) Staging and follow-up of high-grade malignant salivary gland tumours: the role of traditional versus functional imaging approaches\u2014A review. Oral Oncol 60:157\u2013166. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.04.016","journal-title":"Oral Oncol"},{"issue":"4","key":"1833_CR8","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1007\/s13139-013-0222-8","volume":"47","author":"HL Park","year":"2013","unstructured":"Park\u00a0HL, Yoo Ie\u00a0R, Lee\u00a0N, Yoon\u00a0H, Choi\u00a0EK, Choi\u00a0HS et al (2013) The value of F\u201118 FDG PET for planning treatment and detecting recurrence in malignant salivary gland tumors: comparison with conventional imaging studies. Nucl Med Mol Imaging 47(4):242\u2013248. https:\/\/doi.org\/10.1007\/s13139-013-0222-8","journal-title":"Nucl Med Mol Imaging"},{"issue":"3","key":"1833_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/hed.24605","volume":"39","author":"JH Jung","year":"2017","unstructured":"Jung\u00a0JH, Lee\u00a0SW, Son\u00a0SH, Kim\u00a0CY, Lee\u00a0CH, Jeong\u00a0JH et al (2017) Clinical impact of (18) F\u2011FDG positron emission tomography\/CT on adenoid cystic carcinoma of the head and neck. Head Neck 39(3):447\u2013455. https:\/\/doi.org\/10.1002\/hed.24605","journal-title":"Head Neck"},{"issue":"5","key":"1833_CR10","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.7150\/thno.38501","volume":"10","author":"W van Boxtel","year":"2020","unstructured":"van Boxtel\u00a0W, Lutje\u00a0S, van Engen-van Grunsven\u00a0ICH, Verhaegh\u00a0GW, Schalken\u00a0JA, Jonker\u00a0MA et al (2020) (68)Ga-PSMA-HBED-CC PET\/CT imaging for adenoid cystic carcinoma and salivary duct carcinoma: a\u00a0phase 2 imaging study. Theranostics 10(5):2273\u20132283. https:\/\/doi.org\/10.7150\/thno.38501","journal-title":"Theranostics"},{"issue":"10","key":"1833_CR11","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1007\/s00259-017-3737-x","volume":"44","author":"TJW Klein Nulent","year":"2017","unstructured":"Klein Nulent\u00a0TJW, van Es\u00a0RJJ, Krijger\u00a0GC, de Bree\u00a0R, Willems\u00a0SM, de Keizer\u00a0B (2017) Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma\u2014A preliminary analysis. Eur J Nucl Med Mol Imaging 44(10):1614\u20131621. https:\/\/doi.org\/10.1007\/s00259-017-3737-x","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1833_CR12","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.2147\/CMAR.S185542","volume":"10","author":"L Di","year":"2018","unstructured":"Di\u00a0L, Qian\u00a0K, Du\u00a0C, Shen\u00a0C, Zhai\u00a0R, He\u00a0X et\u00a0al (2018) Radiotherapy as salvage treatment of salivary duct carcinoma in major salivary glands without radical operations. Cancer Manag Res 10:6071\u20136078. https:\/\/doi.org\/10.2147\/CMAR.S185542","journal-title":"Cancer Manag Res"},{"issue":"17","key":"1833_CR13","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.21.00449","volume":"39","author":"JL Geiger","year":"2021","unstructured":"Geiger\u00a0JL, Ismaila\u00a0N, Beadle\u00a0B, Caudell\u00a0JJ, Chau\u00a0N, Deschler\u00a0D et\u00a0al (2021) Management of salivary gland malignancy: ASCO guideline. J\u00a0Clin Oncol 39(17):1909\u20131941. https:\/\/doi.org\/10.1200\/JCO.21.00449","journal-title":"J Clin Oncol"},{"issue":"2","key":"1833_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0360-3016(84)90007-5","volume":"10","author":"B Vikram","year":"1984","unstructured":"Vikram\u00a0B, Strong\u00a0EW, Shah\u00a0JP, Spiro\u00a0RH (1984) Radiation therapy in adenoid-cystic carcinoma. Int J Radiat Oncol Biol Phys 10(2):221\u2013223","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"1833_CR15","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/0360-3016(86)90314-7","volume":"12","author":"PJ Fitzpatrick","year":"1986","unstructured":"Fitzpatrick\u00a0PJ, Theriault\u00a0C (1986) Malignant salivary gland tumors. Int J Radiat Oncol Biol Phys 12(10):1743\u20131747","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1833_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijrobp.2006.04.014","volume":"66","author":"AM Chen","year":"2006","unstructured":"Chen\u00a0AM, Bucci\u00a0MK, Weinberg\u00a0V, Garcia\u00a0J, Quivey\u00a0JM, Schechter\u00a0NR et\u00a0al (2006) Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence. Int J Radiat Oncol Biol Phys 66(1):152\u2013159. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.04.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1833_CR17","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/hed.10380","volume":"26","author":"WM Mendenhall","year":"2004","unstructured":"Mendenhall\u00a0WM, Morris\u00a0CG, Amdur\u00a0RJ, Werning\u00a0JW, Hinerman\u00a0RW, Villaret\u00a0DB (2004) Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck 26(2):154\u2013162. https:\/\/doi.org\/10.1002\/hed.10380","journal-title":"Head Neck"},{"issue":"1","key":"1833_CR18","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ijrobp.2015.05.013","volume":"93","author":"AD Jensen","year":"2015","unstructured":"Jensen\u00a0AD, Nikoghosyan\u00a0AV, Lossner\u00a0K, Haberer\u00a0T, Jakel\u00a0O, Munter\u00a0MW et al (2015) COSMIC: a regimen of intensity modulated radiation therapy plus dose-escalated, raster-scanned carbon Ion boost for malignant salivary gland tumors: results of the prospective phase 2 trial. Int J Radiat Oncol Biol Phys 93(1):37\u201346. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.05.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1833_CR19","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.ijrobp.2006.10.044","volume":"67","author":"AM Chen","year":"2007","unstructured":"Chen\u00a0AM, Garcia\u00a0J, Lee\u00a0NY, Bucci\u00a0MK, Eisele\u00a0DW (2007) Patterns of nodal relapse after surgery and postoperative radiation therapy for carcinomas of the major and minor salivary glands: what is the role of elective neck irradiation? Int J Radiat Oncol Biol Phys 67(4):988\u2013994. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.10.044","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"1833_CR20","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.clon.2018.08.018","volume":"30","author":"K Armstrong","year":"2018","unstructured":"Armstrong\u00a0K, Ward\u00a0J, Hughes\u00a0NM, Mihai\u00a0A, Blayney\u00a0A, Mascott\u00a0C et\u00a0al (2018) Guidelines for clinical target volume definition for perineural spread of major salivary gland cancers. Clin Oncol (R Coll Radiol) 30(12):773\u2013779. https:\/\/doi.org\/10.1016\/j.clon.2018.08.018","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"6","key":"1833_CR21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1749-4486.2009.02036.x","volume":"34","author":"AM Chen","year":"2009","unstructured":"Chen\u00a0AM, Garcia\u00a0J, Granchi\u00a0P, Bucci\u00a0MK, Lee\u00a0NY (2009) Base of skull recurrences after treatment of salivary gland cancer with perineural invasion reduced by postoperative radiotherapy. Clin Otolaryngol 34(6):539\u2013545. https:\/\/doi.org\/10.1111\/j.1749-4486.2009.02036.x","journal-title":"Clin Otolaryngol"},{"issue":"17","key":"1833_CR22","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1002\/cncr.29443","volume":"121","author":"AD Jensen","year":"2015","unstructured":"Jensen\u00a0AD, Nikoghosyan\u00a0AV, Poulakis\u00a0M, Hoss\u00a0A, Haberer\u00a0T, Jakel\u00a0O et al (2015) Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival. Cancer 121(17):3001\u20133009. https:\/\/doi.org\/10.1002\/cncr.29443","journal-title":"Cancer"},{"issue":"1","key":"1833_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13014-019-1260-x","volume":"14","author":"M Haderlein","year":"2019","unstructured":"Haderlein\u00a0M, Scherl\u00a0C, Semrau\u00a0S, Lettmaier\u00a0S, Hecht\u00a0M, Putz\u00a0F et\u00a0al (2019) Salivary gland carcinoma (SGC) with perineural spread and\/or positive resection margin\u2014High locoregional control rates after photon (chemo) radiotherapy\u2014Experience from a\u00a0monocentric analysis. Radiat Oncol 14(1):68. https:\/\/doi.org\/10.1186\/s13014-019-1260-x","journal-title":"Radiat Oncol"},{"issue":"11","key":"1833_CR24","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1001\/jamaoto.2016.2168","volume":"142","author":"A Amini","year":"2016","unstructured":"Amini\u00a0A, Waxweiler\u00a0TV, Brower\u00a0JV, Jones\u00a0BL, McDermott\u00a0JD, Raben\u00a0D et\u00a0al (2016) Association of adjuvant chemoradiotherapy vs radiotherapy alone with survival in patients with resected major salivary gland carcinoma: data from the National Cancer Data base. JAMA Otolaryngol Head Neck Surg 142(11):1100\u20131110. https:\/\/doi.org\/10.1001\/jamaoto.2016.2168","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"6","key":"1833_CR25","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/hed.24172","volume":"38","author":"T Tanvetyanon","year":"2016","unstructured":"Tanvetyanon\u00a0T, Fisher\u00a0K, Caudell\u00a0J, Otto\u00a0K, Padhya\u00a0T, Trotti\u00a0A (2016) Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients. Head Neck 38(6):863\u2013870. https:\/\/doi.org\/10.1002\/hed.24172","journal-title":"Head Neck"},{"issue":"8","key":"1833_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/hed.10400","volume":"26","author":"CH Terhaard","year":"2004","unstructured":"Terhaard\u00a0CH, Lubsen\u00a0H, Van der Tweel\u00a0I, Hilgers\u00a0FJ, Eijkenboom\u00a0WM, Marres\u00a0HA et\u00a0al (2004) Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck 26(8):681\u2013692. https:\/\/doi.org\/10.1002\/hed.10400 (discussion 92\u201393)","journal-title":"Head Neck"},{"issue":"7","key":"1833_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1001\/archoto.2009.70","volume":"135","author":"T Tanvetyanon","year":"2009","unstructured":"Tanvetyanon\u00a0T, Qin\u00a0D, Padhya\u00a0T, McCaffrey\u00a0J, Zhu\u00a0W, Boulware\u00a0D et\u00a0al (2009) Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma. Arch Otolaryngol Head Neck Surg 135(7):687\u2013692. https:\/\/doi.org\/10.1001\/archoto.2009.70","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"1833_CR28","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.ijrobp.2010.09.042","volume":"82","author":"JD Schoenfeld","year":"2012","unstructured":"Schoenfeld\u00a0JD, Sher\u00a0DJ, Norris\u00a0CM Jr., Haddad\u00a0RI, Posner\u00a0MR, Balboni\u00a0TA et al (2012) Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy. Int J Radiat Oncol Biol Phys 82(1):308\u2013314. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.09.042","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"Suppl 1","key":"1833_CR29","doi-asserted-by":"publisher","first-page":"E2041","DOI":"10.1002\/hed.24375","volume":"38","author":"M Haderlein","year":"2016","unstructured":"Haderlein\u00a0M, Scherl\u00a0C, Semrau\u00a0S, Lettmaier\u00a0S, Uter\u00a0W, Neukam\u00a0FW et al (2016) High-grade histology as predictor of early distant metastases and decreased disease-free survival in salivary gland cancer irrespective of tumor subtype. Head Neck 38(Suppl 1):E2041\u2013E2048. https:\/\/doi.org\/10.1002\/hed.24375","journal-title":"Head Neck"},{"key":"1833_CR30","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0841","author":"GJ Hanna","year":"2020","unstructured":"Hanna\u00a0GJ, Bae\u00a0JE, Lorch\u00a0JH, Haddad\u00a0RI, Jo\u00a0VY, Schoenfeld\u00a0JD et al (2020) The benefits of adjuvant trastuzumab for HER-2-positive salivary gland cancers. Oncologist. https:\/\/doi.org\/10.1634\/theoncologist.2019-0841","journal-title":"Oncologist"},{"key":"1833_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ejca.2018.12.035","volume":"110","author":"W van Boxtel","year":"2019","unstructured":"van Boxtel\u00a0W, Locati\u00a0LD, van Engen-van Grunsven\u00a0ACH, Bergamini\u00a0C, Jonker\u00a0MA, Fiets\u00a0E et al (2019) Adjuvant androgen deprivation therapy for poor-risk, androgen receptor-positive salivary duct carcinoma. Eur J Cancer 110:62\u201370. https:\/\/doi.org\/10.1016\/j.ejca.2018.12.035","journal-title":"Eur J Cancer"},{"issue":"8","key":"1833_CR32","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.bjoms.2019.07.021","volume":"57","author":"M Garg","year":"2019","unstructured":"Garg\u00a0M, Tudor-Green\u00a0B, Bisase\u00a0B (2019) Current thinking in the management of adenoid cystic carcinoma of the head and neck. Br J Oral Maxillofac Surg 57(8):716\u2013721. https:\/\/doi.org\/10.1016\/j.bjoms.2019.07.021","journal-title":"Br J Oral Maxillofac Surg"},{"issue":"9","key":"1833_CR33","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1002\/lary.26516","volume":"127","author":"A Lee","year":"2017","unstructured":"Lee\u00a0A, Givi\u00a0B, Osborn\u00a0VW, Schwartz\u00a0D, Schreiber\u00a0D (2017) Patterns of care and survival of adjuvant radiation for major salivary adenoid cystic carcinoma. Laryngoscope 127(9):2057\u20132062. https:\/\/doi.org\/10.1002\/lary.26516","journal-title":"Laryngoscope"},{"issue":"18","key":"1833_CR34","doi-asserted-by":"publisher","first-page":"4444","DOI":"10.1002\/cncr.27408","volume":"118","author":"CL Ellington","year":"2012","unstructured":"Ellington\u00a0CL, Goodman\u00a0M, Kono\u00a0SA, Grist\u00a0W, Wadsworth\u00a0T, Chen\u00a0AY et\u00a0al (2012) Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973\u20132007 surveillance, epidemiology, and end results data. Cancer 118(18):4444\u20134451. https:\/\/doi.org\/10.1002\/cncr.27408","journal-title":"Cancer"},{"issue":"1","key":"1833_CR35","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/COC.0b013e3181d26d45","volume":"34","author":"S Lloyd","year":"2011","unstructured":"Lloyd\u00a0S, Yu\u00a0JB, Wilson\u00a0LD, Decker\u00a0RH (2011) Determinants and patterns of survival in adenoid cystic carcinoma of the head and neck, including an analysis of adjuvant radiation therapy. Am J Clin Oncol 34(1):76\u201381. https:\/\/doi.org\/10.1097\/COC.0b013e3181d26d45","journal-title":"Am J Clin Oncol"},{"issue":"10","key":"1833_CR36","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1002\/lary.26565","volume":"127","author":"S Ali","year":"2017","unstructured":"Ali\u00a0S, Palmer\u00a0FL, Katabi\u00a0N, Lee\u00a0N, Shah\u00a0JP, Patel\u00a0SG et al (2017) Long-term local control rates of patients with adenoid cystic carcinoma of the head and neck managed by surgery and postoperative radiation. Laryngoscope 127(10):2265\u20132269. https:\/\/doi.org\/10.1002\/lary.26565","journal-title":"Laryngoscope"},{"issue":"9","key":"1833_CR37","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/j.1445-2197.2008.04643.x","volume":"78","author":"SR Greig","year":"2008","unstructured":"Greig\u00a0SR, Chaplin\u00a0JM, McIvor\u00a0NP, Izzard\u00a0ME, Taylor\u00a0G, Wee\u00a0D (2008) Acinic cell carcinoma of the parotid gland: Auckland experience and literature review. ANZ J Surg 78(9):754\u2013758. https:\/\/doi.org\/10.1111\/j.1445-2197.2008.04643.x","journal-title":"ANZ J Surg"},{"issue":"4","key":"1833_CR38","first-page":"262","volume":"20","author":"PD Spafford","year":"1991","unstructured":"Spafford\u00a0PD, Mintz\u00a0DR, Hay\u00a0J (1991) Acinic cell carcinoma of the parotid gland: review and management. J\u00a0Otolaryngol 20(4):262\u2013266","journal-title":"J Otolaryngol"},{"issue":"1","key":"1833_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s1658-3876(09)50035-0","volume":"2","author":"N Al-Zaher","year":"2009","unstructured":"Al-Zaher\u00a0N, Obeid\u00a0A, Al-Salam\u00a0S, Al-Kayyali\u00a0BS (2009) Acinic cell carcinoma of the salivary glands: a\u00a0literature review. Hematol Oncol Stem Cell Ther 2(1):259\u2013264. https:\/\/doi.org\/10.1016\/s1658-3876(09)50035-0","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"1833_CR40","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1007\/s00405-020-05998-6","volume":"277","author":"M Cavaliere","year":"2020","unstructured":"Cavaliere\u00a0M, De Luca\u00a0P, Scarpa\u00a0A, Savignano\u00a0L, Cassandro\u00a0C, Cassandro\u00a0E et\u00a0al (2020) Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a\u00a0literature review. Eur Arch Otorhinolaryngol 277(10):2673\u20132679. https:\/\/doi.org\/10.1007\/s00405-020-05998-6","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"5","key":"1833_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archoto.2012.226","volume":"138","author":"MT Andreoli","year":"2012","unstructured":"Andreoli\u00a0MT, Andreoli\u00a0SM, Shrime\u00a0MG, Devaiah\u00a0AK (2012) Radiotherapy in parotid acinic cell carcinoma: does it have an impact on survival? Arch Otolaryngol Head Neck Surg 138(5):463\u2013466. https:\/\/doi.org\/10.1001\/archoto.2012.226","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"9","key":"1833_CR42","doi-asserted-by":"publisher","first-page":"877","DOI":"10.2217\/fon-2017-0468","volume":"14","author":"XS Sun","year":"2018","unstructured":"Sun\u00a0XS, Michel\u00a0C, Babin\u00a0E, De Raucourt\u00a0D, Pechery\u00a0A, Gherga\u00a0E et\u00a0al (2018) Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC. Future Oncol 14(9):877\u2013889. https:\/\/doi.org\/10.2217\/fon-2017-0468","journal-title":"Future Oncol"},{"issue":"5","key":"1833_CR43","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/j.ijrobp.2019.05.048","volume":"104","author":"TVV Thomas","year":"2019","unstructured":"Thomas\u00a0TVV, Packianathan\u00a0S, Bhanat\u00a0E, Albert\u00a0AA, Abraham\u00a0A, Gordy\u00a0X et\u00a0al (2019) Management of oligometastatic squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 104(5):1191. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.05.048","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"1833_CR44","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","volume":"196","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger\u00a0M, Baus\u00a0WW, Blanck\u00a0O, Combs\u00a0SE, Debus\u00a0J, Engenhart-Cabillic\u00a0R et al (2020) Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 196(5):417\u2013420. https:\/\/doi.org\/10.1007\/s00066-020-01603-1","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1833_CR45","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s00066-020-01583-2","volume":"196","author":"D Schmitt","year":"2020","unstructured":"Schmitt\u00a0D, Blanck\u00a0O, Gauer\u00a0T, Fix\u00a0MK, Brunner\u00a0TB, Fleckenstein\u00a0J et\u00a0al (2020) Technological quality requirements for stereotactic radiotherapy: expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy. Strahlenther Onkol 196(5):421\u2013443. https:\/\/doi.org\/10.1007\/s00066-020-01583-2","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1833_CR46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00066-018-1416-x","volume":"195","author":"L Wilke","year":"2019","unstructured":"Wilke\u00a0L, Andratschke\u00a0N, Blanck\u00a0O, Brunner\u00a0TB, Combs\u00a0SE, Grosu\u00a0AL et\u00a0al (2019) ICRU report 91 on prescribing, recording, and reporting of stereotactic treatments with small photon beams: statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery. Strahlenther Onkol 195(3):193\u2013198. https:\/\/doi.org\/10.1007\/s00066-018-1416-x","journal-title":"Strahlenther Onkol"},{"issue":"18","key":"1833_CR47","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez\u00a0DR, Tang\u00a0C, Zhang\u00a0J, Blumenschein\u00a0GR Jr., Hernandez\u00a0M, Lee\u00a0JJ et al (2019) Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a\u00a0multi-institutional, phase II, randomized study. J\u00a0Clin Oncol 37(18):1558\u20131565. https:\/\/doi.org\/10.1200\/JCO.19.00201","journal-title":"J Clin Oncol"},{"issue":"1","key":"1833_CR48","doi-asserted-by":"publisher","first-page":"e173501","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar\u00a0P, Wardak\u00a0Z, Gerber\u00a0DE, Tumati\u00a0V, Ahn\u00a0C, Hughes\u00a0RS et al (2018) Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a phase 2 randomized clinical trial. JAMA Oncol 4(1):e173501. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3501","journal-title":"JAMA Oncol"},{"issue":"10162","key":"1833_CR49","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/S0140-6736(18)32486-3","volume":"392","author":"CC Parker","year":"2018","unstructured":"Parker\u00a0CC, James\u00a0ND, Brawley\u00a0CD, Clarke\u00a0NW, Hoyle\u00a0AP, Ali\u00a0A et\u00a0al (2018) Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a\u00a0randomised controlled phase 3 trial. Lancet 392(10162):2353\u20132366. https:\/\/doi.org\/10.1016\/S0140-6736(18)32486-3","journal-title":"Lancet"},{"issue":"13","key":"1833_CR50","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1016\/S1470-2045(15)00007-8","volume":"16","author":"AB Sharabi","year":"2015","unstructured":"Sharabi\u00a0AB, Lim\u00a0M, DeWeese\u00a0TL, Drake\u00a0CG (2015) Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy. Lancet Oncol 16(13):e498\u2013e509. https:\/\/doi.org\/10.1016\/S1470-2045(15)00007-8","journal-title":"Lancet Oncol"},{"issue":"25","key":"1833_CR51","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma\u00a0DA, Olson\u00a0R, Harrow\u00a0S, Gaede\u00a0S, Louie\u00a0AV, Haasbeek\u00a0C et al (2020) Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J\u00a0Clin Oncol 38(25):2830\u20132838. https:\/\/doi.org\/10.1200\/JCO.20.00818","journal-title":"J Clin Oncol"},{"issue":"1","key":"1833_CR52","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1186\/s12885-019-5977-6","volume":"19","author":"DA Palma","year":"2019","unstructured":"Palma\u00a0DA, Olson\u00a0R, Harrow\u00a0S, Correa\u00a0RJM, Schneiders\u00a0F, Haasbeek\u00a0CJA et al (2019) Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): study protocol for a\u00a0randomized phase III trial. BMC Cancer 19(1):816. https:\/\/doi.org\/10.1186\/s12885-019-5977-6","journal-title":"BMC Cancer"},{"issue":"2","key":"1833_CR53","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.radonc.2018.02.016","volume":"127","author":"RJ Klement","year":"2018","unstructured":"Klement\u00a0RJ, Hoerner-Rieber\u00a0J, Adebahr\u00a0S, Andratschke\u00a0N, Blanck\u00a0O, Boda-Heggemann\u00a0J et al (2018) Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy. Radiother Oncol 127(2):246\u2013252. https:\/\/doi.org\/10.1016\/j.radonc.2018.02.016","journal-title":"Radiother Oncol"},{"issue":"1","key":"1833_CR54","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12885-018-4191-2","volume":"18","author":"N Andratschke","year":"2018","unstructured":"Andratschke\u00a0N, Alheid\u00a0H, Allg\u00e4uer\u00a0M, Becker\u00a0G, Blanck\u00a0O, Boda-Heggemann\u00a0J et al (2018) The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474\u00a0patients with 623 metastases. BMC Cancer 18(1):283. https:\/\/doi.org\/10.1186\/s12885-018-4191-2","journal-title":"BMC Cancer"},{"issue":"1","key":"1833_CR55","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger\u00a0M, Lievens\u00a0Y, Bouma\u00a0AB, Collette\u00a0L, Dekker\u00a0A, deSouza\u00a0NM et\u00a0al (2020) Characterisation and classification of oligometastatic disease: a\u00a0European society for radiotherapy and oncology and European organisation for research and treatment of cancer consensus recommendation. Lancet Oncol 21(1):e18\u2013e28. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1","journal-title":"Lancet Oncol"},{"key":"1833_CR56","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.oraloncology.2016.06.019","volume":"60","author":"E Orlandi","year":"2016","unstructured":"Orlandi\u00a0E, Iacovelli\u00a0NA, Bonora\u00a0M, Cavallo\u00a0A, Fossati\u00a0P (2016) Salivary gland. Photon beam and particle radiotherapy: present and future. Oral Oncol 60:146\u2013156. https:\/\/doi.org\/10.1016\/j.oraloncology.2016.06.019","journal-title":"Oral Oncol"},{"issue":"10","key":"1833_CR57","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1002\/lary.27844","volume":"129","author":"CA Bollig","year":"2019","unstructured":"Bollig\u00a0CA, Zitsch\u00a0RP 3rd (2019) Impact of treating facilities\u2019 type and volume in patients with major salivary gland cancer. Laryngoscope 129(10):2321\u20132327. https:\/\/doi.org\/10.1002\/lary.27844","journal-title":"Laryngoscope"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00066-021-01833-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-021-01833-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T13:05:07Z","timestamp":1643115907000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00066-021-01833-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,24]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["1833"],"URL":"https:\/\/doi.org\/10.1007\/s00066-021-01833-x","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"type":"print","value":"0179-7158"},{"type":"electronic","value":"1439-099X"}],"subject":[],"published":{"date-parts":[[2021,8,24]]},"assertion":[{"value":"27 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0von der Gr\u00fcn, C.\u00a0R\u00f6del, S.\u00a0Semrau, P.\u00a0Balermpas, D.\u00a0Martin, R.\u00a0Fietkau, and M.\u00a0Haderlein declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}